Home » Topics » BioWorld Science

BioWorld Science
RSS

Cyclolignan derivatives disclosed

June 21, 1996

Toyama's T-614 enters phase I in U.K.

June 21, 1996

Albenza receives U.S. marketing approval

June 21, 1996

Y-ART-3: Promising HIV treatment candidate

June 21, 1996

HIV protease inhibitors from Warner-Lambert

June 21, 1996

Alpha-glucosidase inhibitors from Seikagaku Kogyo

June 21, 1996

Positive analysis results for Amphotec

June 21, 1996

AmBisome line extension receives Danish approval

June 21, 1996

FDA approves abbreviated treatment regimen for Vantin

June 21, 1996

Antifungal sordarin derivatives reported by Glaxo Wellcome

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...